Author profile

Bryan Bednarz, PhD

Department of Medical Physics, University of Wisconsin-Madison

AuthorsPoster
Sensitivity of Dosimetry Calculations to Tumor Segmentation Methods on SPECT/CT Images for Patients Undergoing 177 Lu-PSMA-617 Radiopharmaceutical Therapy (RPT)

Radiopharmaceutical therapy (RPT) delivers targeted radiation to cancer cells. Patient‑specific dosimetry can help estimate dose and predict treatment outcome. However, tumor segmentation approaches vary across institutions, introducing uncertainty into dose...

Poster Program · Radiopharmaceuticals, Theranostics, and Nuclear Medicine
CorrespondingsPaper
BEST IN PHYSICS (THERAPY): Tumor Dose Heterogeneity Informed Biological Optimization of Combination Lu-177 PSMA Radiopharmaceutical Therapy and Ir-192 High Dose Rate Prostate Brachytherapy

Focal dose escalation to the dominant intraprostatic lesion (GTV) improves biochemical control but is limited by urethral toxicity. 177Lu-PSMA radiopharmaceutical therapy (RPT) offers a targeted boost, yet its spatial heterogeneity in uptake leaves GTV sub-re...

Proffered Program · Therapy Physics